Hepatitis from Greater celandine (Chelidonium majus L.): Review of literature and report of a new case

被引:52
作者
Moro, Paola A. [1 ]
Cassetti, Federica [1 ]
Giugliano, Gianni [2 ]
Falce, Maria T. [2 ]
Mazzanti, Gabriela [3 ]
Menniti-Ippolito, Francesca [4 ]
Raschetti, Roberto [4 ]
Santuccio, Carmela [5 ]
机构
[1] Osped Niguarda Ca Granda, Poison Control Ctr, I-20162 Milan, Italy
[2] Sapri Hosp ASL SA 3, Dept Internal Med, Sapri, Italy
[3] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy
[4] Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy
[5] Italian Med Agcy, Pharmacovigilance Unit, Rome, Italy
关键词
Greater celandine; Chelidonium majus; Complementary therapies; Acute cholestatic hepatitis; Self-medication;
D O I
10.1016/j.jep.2009.04.036
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Folk medicine is a rich source of useful therapeutic tools. Nevertheless, use of medicinal plants can have unwanted, negative effects. By means of the description of an adverse reaction to a herbal remedy, we highlight the need for better efficacy-toxicity studies on these products. Aim of the Study: To report a case of possible Chelidonium majus L. (Greater celandine)-induced hepatitis and evaluate the past published cases. Materials and methods: We outlined the main features of hepatitis associated with use of Chelidonium majus by providing a review of cases reported and analysing in detail a new one. Results: Several cases of acute hepatitis related to Greater celandine consumption were found in the literature. The assessment for causality using Naranjo probability scale showed a probable relationship between the liver injury and the consumption of Chelidonium majus in the case we described. Conclusions: Our case, along with the other ones reported in the literature, increases the concern about the safety of oral use of Chelidonium majus. Plants used in traditional medicine are not necessarily harmless. Customers and prescribers should be aware of this, especially when a herbal drug is used with therapeutic purposes in absence of reliable studies of clinical efficacy and benefit-risk assessment. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 23 条
[1]
ABT L, 2002, CELANDINE ALTERNATIV, V137
[2]
Acute hepatitis induced by greater celandine (Chelidonium majus) [J].
Benninger, J ;
Schneider, HT ;
Schuppan, D ;
Kirchner, T ;
Hahn, EG .
GASTROENTEROLOGY, 1999, 117 (05) :1234-1237
[3]
Evaluation of the correlation and regression relationships between the concentrations of alkaloids and chemical elements in individual greater celandine (Chelidonium majus L.) plants [J].
Buzuk G.N. ;
Lovkova M.Y. ;
Sokolova S.M. ;
Tyutekin Y.V. .
Doklady Biological Sciences, 2002, 387 (1-6) :562-564
[4]
Pharmacological activities of Chelidonium majus L (Papaveraceae) [J].
Colombo, ML ;
Bosisio, E .
PHARMACOLOGICAL RESEARCH, 1996, 33 (02) :127-134
[5]
Crijns A P G, 2002, Ned Tijdschr Geneeskd, V146, P124
[6]
Safety concerns about kava not unique [J].
De Smet, PAGM .
LANCET, 2002, 360 (9342) :1336-1336
[7]
deMiguel CV, 1997, MED CLIN-BARCELONA, V108, P599
[8]
*EDQM HEALTHC, 2006, MON EDQM, V1861, P1690
[9]
Ukrain - a new cancer cure? A systematic review of randomised clinical trials [J].
Ernst, E ;
Schmidt, K .
BMC CANCER, 2005, 5 (1)
[10]
ESCOP Monographs, 2003, MON SCI FDN HERB MED, P74